Zoryve 0.3% foam 60GM
Ended Awarded
- Contract number
- SPE2DB25FQ4S0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,582
Award facts
- Contract value 100% obligated
- $12,582.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,582.30 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This non-competitive delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025, and represents a firm fixed-price transaction. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 through December 2026 that provides comprehensive pharmaceutical and medical supply support for military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support defense and veteran healthcare systems. The company's role as a prime pharmaceutical vendor demonstrates its established capability to meet federal procurement requirements, with its contract portfolio spanning multiple therapeutic domains and supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order for ZORYVE foam reflects the company's ongoing role in providing specialized pharmaceutical products to military medical supply chains.
Quick answers
Who was awarded contract SPE2DB25FQ4S0?
SPE2DB25FQ4S0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FQ4S0 worth?
The government has obligated $12,582 on SPE2DB25FQ4S0.
Is contract SPE2DB25FQ4S0 an order under another contract?
Yes. SPE2DB25FQ4S0 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ4S0 competed?
The extent of competition for SPE2DB25FQ4S0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award